Page last updated: 2024-08-17

aspartic acid and exenatide

aspartic acid has been researched along with exenatide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Donnelly, D; Mann, RJ; Nasr, NE; Paci, E; Sinfield, JK1
Cai, ZL; Chun, CK; Hsieh, YS; Payne, RJ; Reimers, JR; Thomas, GL1
Auclair, JR; Liu, S; Moulton, KR; Zhou, ZS1
Balbi, M; Fedele, E; Passalacqua, M; Rebosio, C; Ricciarelli, R1
Guo, L; Li, C; Man, F; Pan, Q; Wang, W; Wang, X; Wu, MX; Xian, TZ; Zhang, J; Zhang, X1

Trials

1 trial(s) available for aspartic acid and exenatide

ArticleYear
Comparing the effects of twice-daily exenatide and insulin on renal function in patients with type 2 diabetes mellitus: secondary analysis of a randomized controlled trial.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022, Volume: 70, Issue:7

    Topics: Aspartic Acid; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kidney; Obesity; Overweight; Peptides; Venoms

2022

Other Studies

4 other study(ies) available for aspartic acid and exenatide

ArticleYear
The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
    British journal of pharmacology, 2010, Volume: 160, Issue:8

    Topics: Animals; Aspartic Acid; Binding Sites; Binding, Competitive; Cell Line; Exenatide; Glucagon-Like Peptide-1 Receptor; Glutamic Acid; Humans; Hydrogen Bonding; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Peptides; Protein Conformation; Protein Structure, Tertiary; Radioligand Assay; Rats; Receptors, Glucagon; Recombinant Proteins; Serine; Structure-Activity Relationship; Transfection; Venoms

2010
Peptide ligations accelerated by N-terminal aspartate and glutamate residues.
    Organic letters, 2011, Sep-16, Volume: 13, Issue:18

    Topics: Aspartic Acid; Catalysis; Esters; Exenatide; Glutamic Acid; Hypoglycemic Agents; Molecular Structure; Peptides; Stereoisomerism; Sulfhydryl Compounds; Venoms

2011
Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.
    Amino acids, 2016, Volume: 48, Issue:4

    Topics: Adrenocorticotropic Hormone; Amides; Amino Acid Sequence; Animals; Artifacts; Asparagine; Aspartic Acid; Buffers; Calmodulin; Cattle; Exenatide; Hydrogen-Ion Concentration; Isoaspartic Acid; Peptides; Protein Processing, Post-Translational; Proteolysis; Serine Endopeptidases; Solutions; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Venoms

2016
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.
    BioFactors (Oxford, England), 2018, Volume: 44, Issue:2

    Topics: Adenylyl Cyclases; Animals; Aspartic Acid; Cerebral Cortex; Cyclic AMP; Dideoxyadenosine; Evoked Potentials; Exenatide; gamma-Aminobutyric Acid; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glutamic Acid; Hippocampus; Male; Mice; Mice, Inbred C57BL; Peptides; Presynaptic Terminals; Receptors, Presynaptic; Synaptosomes; Venoms

2018